CDNA Stock-Based Compensation
$36.97MTTM · USD
Period ending:
CDNA FY Stock-Based CompUSD
$66.41M$0.00
2012-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
CDNA stock-based compensation history
Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 34,864,000 | |
| 66,406,000 | |
| 49,086,000 | |
| 46,553,000 | |
| 36,081,000 | |
| 23,401,000 | |
| 22,417,000 | |
| 7,138,000 | |
| 1,744,000 | |
| 1,998,000 | |
| 1,341,000 | |
| 535,000 | |
| 72,000 | |
| 69,000 |
Compare stock-based compensation
All CDNA financial metrics · CDNA stock overview · How to interpret financial metrics
